Neuphoria Therapeutics (NEUP) Exchange Rate Effect (2023 - 2026)

Neuphoria Therapeutics (NEUP) has reported Exchange Rate Effect for 4 consecutive years, with $527059.0 the latest figure, recorded in Q1 2026.

• On a quarterly basis, Exchange Rate Effect rose 520.3% year-over-year to $527059.0 in Q1 2026; TTM through Mar 2026 was $852616.0, a 4384.86% increase from a year earlier, with the FY2025 full-year figure at -$3750.0, down 104.87% from the prior year.
• Exchange Rate Effect was $527059.0 for Q1 2026 at Neuphoria Therapeutics, up from $295406.0 in the prior quarter.
• Over five years, Exchange Rate Effect peaked at $527059.0 in Q1 2026 and troughed at -$276692.0 in Q4 2024.
• A 4-year average of $79657.6 and a median of $72367.0 in 2024 frame the typical range for Exchange Rate Effect.
• Across the five-year window, Exchange Rate Effect plunged 180.61% in 2024 and soared 520.3% in 2026, its largest moves.
• Over 4 years, Exchange Rate Effect stood at $343242.0 in 2023, then sank by 180.61% to -$276692.0 in 2024, then surged by 206.76% to $295406.0 in 2025, then jumped by 78.42% to $527059.0 in 2026.
• The last three Exchange Rate Effect figures came in at $527059.0 (Q1 2026), $295406.0 (Q4 2025), and -$19455.0 (Q3 2025), per Business Quant data.